EurekaBio
Empower CGT | In Vivo CAR-T
China · $40.0M raised
- Business Model
- B2B
- Website
- eurekabio.com
- Total Funding
- $40.0M
- Last Round
- Extension RoundFeb 2024
- Rounds
- 2
About
Chinese biotech startup developing the EuLV Lentiviral Vector Production System for scalable, GMP-compliant lentiviral vector manufacturing used in cell and gene therapy.
Summary
EurekaBio is a Biotech company based in China. It has raised $40.0M in total across 2 rounds, most recently a Extension Round round in Feb 2024. Investors include Eight Roads Ventures and F-Prime Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.